Buy ISRG by May 22, 2025.

I’m telling you guys this is the APPLE of robotic surgery. The king of robotic surgery with its da Vinci system, and the new FDA-cleared da Vinci 5 keeps it ahead of the game with cutting-edge precision. The company’s killing it—18% more procedures and a 25% revenue spike to $2.41B in Q4 2024, plus a 15% jump in installed systems to 9,902 globally. They rake in steady cash from instruments and services (part of their $8.4B 2024 revenue, up 17%), …